MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
ARCH Venture Partners - (#8 Healthcare Investor 2013) WBT
Finance & Acquisitions: Arch Ventures
*Portfolio Companies: Arch Ventures
Semma Therapeutics
Attachments
Home
Parents
*Architects: Diabetes, Metabolic Disease, Dialysis, Renal & Kidney Companies (Pharmaceuticals, Biotechnology, Biosimilars)
*Portfolio Companies: Arch Ventures
Architects: Biotechnology_Stem Cell Therapeutics
Companies: Acquired_(M&A)
Finance & Acquisition: Vertex
Children
2019: Vertex plunks down $950M for stem cell player Semma Therapeutics
Bastiano Sanna, CEO. Sanna, formerly the COO, Magenta Therapeutics and global head of stem cell transplant programs at Novartis (2019)
Douglas Melton, Ph.D., founded Semma in 2014
Jumps
Novartis AG (NYSE: NVS)*